RXRX Competitors & Alternatives
Compare Recursion Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RXRX
Main Stock$3.58
Tradestie Score
52
Market Cap
$2.23B
Revenue Growth
-0.6%
Analyst Upside
+104.7%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.53
|
$2.08B | - | 59 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.27
|
$2.02B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.12
|
$2.01B | - | 46 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.10
|
$1.97B | - | 62 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$6.62
|
$1.92B | - | 62 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$64.94
|
$1.92B | - | 57 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$39.38
|
$1.90B | 26.2 | 52 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$28.83
|
$1.84B | - | 65 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.08
|
$1.81B | - | 42 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.42
|
$1.78B | - | 66 | Compare |
More RXRX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry